However, unlike patients with myocardial infarction, there is little guidance to be found in how to treat and follow up patients with elevated hs-cTnT and no myocardial infarction and no evidence exists that patients with increased hs-cTnT would need urgent management for ischemic disease [7]. This evidence concerns the gene TNNT2 and myocardial infarction.